Straits Times Index
3,101.93 +9.82 (+0.32%) Nikkei
28,029.57 +276.20 (+1.00%) Hang Seng
23,766.69 -22.24 (-0.09%) FTSE 100
7,122.32 -6.89 (-0.10%) BTC-USD
53,857.59 -3,087.47 (-5.42%) CMC Crypto 200
1,366.41 -75.35 (-5.23%)
Amyris, Inc. (AMRS)
After hours:
| Previous close | 5.96 |
| Open | 5.83 |
| Bid | 5.65 x 36200 |
| Ask | 5.75 x 3000 |
| Day's range | 5.48 - 5.89 |
| 52-week range | 2.72 - 23.42 |
| Volume | |
| Avg. volume | 4,972,516 |
| Market cap | 1.757B |
| Beta (5Y monthly) | 1.44 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
Why Shares of Amyris Are Plummeting This Week
Consistent with the falling temperatures outside, investors are turning a cold shoulder to synthetic biology specialist Amyris (NASDAQ: AMRS) this week. As of the close of the trading session on Thursday, shares of Amyris have plunged 47% from their closing price of $14.09 last Friday. Beginning the week on an inauspicious note, Amyris reported third-quarter 2021 earnings after the market closed on Monday.
- Motley Fool
Why Shares of Amyris Are Getting Crushed Today
Failing to deliver on both the top and bottom lines, synthetic-biology specialist Amyris (NASDAQ: AMRS) reported disappointing third-quarter 2021 earnings results yesterday after the market closed. In addition, investors are selling shares after learning that the company is raising capital through the issuance of senior convertible notes. Although the company reported a year-over-year sales increase of 39.7%, it didn't seem to be enough to satisfy investors' appetites.
- Motley Fool
Amyris Inc (AMRS) Q3 2021 Earnings Call Transcript
AMRS earnings call for the period ending September 30, 2021.
